Depression associated with stroke affects roughly one-third of stroke survivors. Poststroke depression (PSD) is thought to adversely influence functional outcome by limiting participation in rehabilitation, decreasing physical, social, and cognitive function, and affecting neuroplasticity thereby placing stroke survivors at high risk for future vascular events. PSD has also been associated with higher mortality rates after stroke.
| INTRODUCTION

| Burden of stroke
The Sustainable Development Goals (SDGs) represent the main global concerns proposed by world leaders to be solved by 2030. Among their specific targets, to strengthen capacities in low-and middleincome countries (LMIC) for risk reduction of global health risks is a major concern. 1 In that context, stroke, a major cardiovascular disease, merits attention.
Globally, stroke affects >60 million people and the overwhelming majority of them live in low-and middle-income countries LMIC, [2] [3] [4] thereby exacting tremendous societal and economic tolls. 5 Moreover, while stroke mortality rates have dropped modestly due to better medical treatments, the number of individuals living with the residual effects of stroke worldwide is rising. 6 Roughly, 75% of patients survive a first stroke, and of these patients, 25% are left with a minor disability and 40% experience moderate-to-severe disabilities. 7 Beyond the lingering physical, psychological, and social effects of a first stroke, up to 25% of stroke survivors have recurrent strokes, 8 and the morbidity and mortality after a recurrent stroke is worse than that of a primary stroke, with a near doubling of the 30-day fatality rate after a first recurrent stroke vs a first-ever stroke. 9 In Latin America, stroke is the fourth leading cause of years of life lost (YLL). 10 In Peru, stroke is the fifth leading cause of YLL, 10 and stroke is proportionally responsible for even greater rates of disability and death, than in high-income countries like the USA. 11, 12 While there is no national stroke program for stroke in Peru, 13 stroke is listed as a leading cause of disease burden for national priority setting purposes. 14 
| Post-stroke depression (PSD)
Stroke is strongly linked to the three dreaded "Ds": disability, death, and dementia. 15 However, mounting evidence shows that stroke is linked to another dreaded "D," depression. Depression roughly affects one-third of stroke survivors with a cumulative incidence of 55%. 16, 17 Post-stroke depression (PSD) adversely affects stroke recovery by limiting participation in rehabilitation, decreasing physical, social, and cognitive function, and compromising the biologic process of neuroplasticity. [18] [19] [20] Further, PSD increases the risk of dying after a first stroke, and experiencing recurrent strokes, presumably due to the decreased motivation associated with PSD, leading to lesser patient willingness to adhere to preventive therapies. [21] [22] [23] In Peru, PSD has been poorly addressed, and very few published studies have explored the relationship between depressive symptoms and stroke. A study from 2006 at a public hospital setting in Lima, Peru's capital, found that 67% of 180 stroke patients suffered from depression at 1 year after the index stroke. 24 Another study, published in 2009, reported that the prevalence of stroke was 24% higher among people who had depressive episodes compared to those without it. 25 Finally, in 2011 and among stroke patients, severe disability and dependence was found to be 40% higher among stroke survivors suffering with depression in comparison with those without depression. 26 
| Challenges with stroke and mental healthcare in LMIC
Most healthcare systems are acute care-oriented, specialist-centered, urban-located, and fragmented and are thus ill-prepared to deal with chronic conditions, especially in LMIC. 27, 28 For patients in these poorly resourced regions, optimal care is far below evidence-based standards, and to rely on the relatively few overwhelmed specialists alone to provide such services is not only unrealistic, but also unsustainable. 29 A similar situation characterizes mental health services in most LMIC, where rates of depression and anxiety reach almost 70%, 30 there is a shortage and inefficient distribution of professionals, 31 and evidence-based treatments are usually not available or accessible for low-income populations. In this context, an innovative strategy to overcome the health system's limitations in stroke and mental health care is needed.
| EVIDENCE-BASED MANAGEMENT OF PSD
Evidence suggests that pharmacological treatments may reduce depression symptoms among PSD patients. 32, 33 However, it can also increase the risk of adverse events, which means its use as a treatment option should be carefully monitored. 33 In addition, there are limitations in access to pharmacological treatments due to a paucity of financial and human resources for mental health in an LMIC setting like Peru, where there is a ratio of 0.57 psychiatrists per 100 000 inhabitants. 34 In contrast, psychological interventions are a promising treatment option for PSD. 35 Among them, cognitive behavioral therapy (CBT)
has shown positive results in reducing depressive symptoms in patients with PSD. 36 CBT presents an alternative worth exploring 37 as it addresses the particular needs of these patients through a focus on problem-solving approach and skills enhancing. 38 CBT is one of the most effective and economic psychotherapies in general populations, 39, 40 including older adults, [41] [42] [43] who are at higher risk of depression after stroke. 44 Moreover, Internet-delivered CBT has shown promising given the current technological advance in the world. 45 Currently, several CBT programs have been assessed with positive results in the management of depression and anxiety. 46, 47 It has also been reported that minorities, often underserved, are more engaged to this programs, and thus achieve better results. 48 However, it is of note that delivery CBT for depression through virtual environments has dealt with several barriers such as important dropout rates. 49, 50 This is important as a meta-analysis reported a number needed to treat of eight for Internet delivery CBT to have a reduction of 50% in depressive symptoms. 39 In that scenario, a fair solution will be to implement CBT with other strategies that have proven to be effective for patients with stroke or patients with depression, which combined may be helpful for PSD.
For instance, evidence supports the introduction of self-help interventions to mental health treatment. 51 In the case of patients with stroke, preliminary data on self-management interventions indicate an improvement in quality of life, confidence in recovery, and disability outcomes. 52 Support groups are also beneficial in reducing depression in other populations, such as women with breast cancer 53,54 and dementia caregivers. 55 For patients with stroke, there is evidence that participation in these groups may help increase physical functionality and improve recovery. 56 
| TECHONOLOGY AS AN OPPORTUNITY
| Using mHealth to address mental health disorders
A 10-fold increase in cell phone use, Internet connectivity, and digital health technology in LMIC in the last 10 years presents an opportunity for improvements in healthcare delivery and population-based outcomes. 57 The use of mobile phones and Internet creates an opportunity to overcome large distances and mobility limitations, opening new communication channels between patients and providers. 51, [58] [59] [60] In recent years, use of mHealth to address health problems has risen, including its applications for mental health [61] [62] [63] and chronic diseases. [64] [65] [66] For patients with stroke, mHealth has helped patients follow a rehabilitation program, receive support via phone calls, and monitor the recovery process, all effectively improving physical function. [67] [68] [69] Other applications for mHealth involve use of video calls between the patients and therapists, which help reduce the number of therapist visits needed to achieve significant recovery outcomes, in comparison with standard care. 70 In mental health, text messages have shown a positive impact on medication adherence, appointment attendance, symptom monitoring, and overall satisfaction with health services. 62 Such messages typically consist of providing support, reminders, and information.
Likewise, there is evidence that mHealth interventions for depression and anxiety are an effective approach to provide mental health care, particularly for patients who otherwise would not receive any treatment. 61, 63, 71 Use of applications (apps) for depression treatment has also seen a rise in availability and use, with CBT being one of the most used models for its development. 61, 63 However, there is still limited evidence of the effectiveness of using these apps, as well as limited evidence of its use for PSD, which calls for researchers to fill this knowledge gap. 
| Status of mHealth studies in stroke patients
In high-income countries, mHealth apps with educational content on stroke symptoms have been used to assist the lay public and care providers to recognize stroke, facilitate emergency responses, and enhance risk assessment for prompt recognition and management of stroke thus resolving delays in health seeking after stroke which is a major barrier to fostering good acute stroke outcomes. [73] [74] [75] In resource-replete regions, telemedicine-based interventions, adapted to an mHealth-based platform, have been shown to expedite access to safe administration of thrombolytic treatment. [76] [77] [78] Nonetheless, it should be noted that despite the surge in mobile health applications, there are still comparatively few culturally appropriate and sustainable stroke-specific apps 79 and most published data focus on the prestroke or ultra-early stroke (within hours of onset) timepoints, not the post-stroke timepoints (days, weeks, months after onset), the latter of which is typical in LMIC. Enhancing post-stroke outcomes by addressing PSD via culturally relevant mHealth interventions will likely be a useful approach toward improving stroke outcomes in LMIC.
| THE WAY FORWARD FOR PSD
| Peru as a potential case and test study
As previously mentioned, stroke is a leading cause of death and disability in Peru, 11, 12 a country where there is no national stroke program. 13 A stroke event in an average Peruvian family changes the life of the stroke survivor and caregivers in an economically and social manner. Additionally, a large number of stroke patients in Peru receive inadequate post-stroke care, far below evidence-based standards. 80 A similar situation is found for mental disorders which, despite their high burden and prevalence, are commonly underdiagnosed and barely treated. The treatment gap for mental disorders in Peru is between 75% and 85%, a situation explained by the scarcity and centralization of financial and human resources. 81 The plight of stroke survivors suffering PSD in Peru, ranging from 38% to 67% according to local studies, [24] [25] [26] is even worse, because dependency and impoverished conditions make it challenging to use ambulatory services, leading to inadequate monitoring.
Peru is an ideal setting to address PSD through mHealth because of these challenges, but mainly because recent improvements that must be seen as opportunities. First, there has been an enormous expansion of mobile technologies and Internet access. In 2013, 91% of households in Lima, Peru's capital, had at least one family member with access to a cell phone and 64% of Lima residents used the Internet. 82 The expected number of Peruvian smartphone users in 2018 is 10.5 million, almost twice the number in 2014. 83 Second, a mental health reform is underway in Peru, 84 aiming to guarantee availability of mental healthcare services through a community-based model.
84,85
| Role of implementation science
As a mental health reform is currently taking place in Peru, 84 researchers need to plan their interventions foreseeing the possibility that these will have to be implemented in real situations, beyond experimentation-only approaches. Addressing post-stroke care and PSD in LMIC will necessitate engagement of policy makers and other stakeholders. 86 Hence, the evaluation of barriers and facilitators for both developing suitable interventions and their subsequent implementation is also warranted. 87 Recruiting adequate expertise within prevailing research teams in conducting mixed-methods studies and developing complex interventions would be important, including knowledge of hybrid effectiveness-implementation designs. 88 Implementation end points such as acceptability, adoption, appropriateness, feasibility, fidelity and costs, as well as sustainability would need to be defined and captured. 89, 90 It is anticipated that "hybrid studies require more research expertise and personnel, and larger budgets, than non-hybrid designs." 88 
| An intervention concept to address PSD in Peru
Consideration could be given to designing, developing, and evaluating an evidence-based mHealth intervention to address PSD in a LMIC setting like Peru. Following a comprehensive review of the literature and assessment of expert scientific statements, as well as our own published and first-hand practical experience with scientific investigation and healthcare delivery in Peru, we propose a-three-phased approach named iMOODS-Investigating mHealth in overcoming occurrence of depression after stroke. The iMOODS intervention is based on building and delivering a digital platform to facilitate the selfmanagement of PSD. By following three sequential phases, that is, formative, production, and integration + testing, we plan to bridge the several bottlenecks that hamper attending PSD in LMIC.
| Formative phase
This phase would aim to explore stroke patients' needs and perceptions regarding mental health treatment and to identify barriers and facilitators for the use of digital technologies among stroke patients.
A qualitative approach needs to be used in this phase as it allows capture in-depth information not only from past and current experiences of stroke survivors but also from their future expectancies about the delivery of stroke care.
This qualitative study is also crucial to understand the interven- 
| Production phase
| Integration and testing phase
This phase would aim to assemble all the components developed and test them, using effectiveness-implementation hybrid designs. 88 Hybrid designs are studies that allow to test the effects of an intervention while focusing on gathered information to also assess implementation outcomes. 89 In addition to demonstrate effectiveness, iMOODS requires to identify implementation strategies for challenging low-income settings to introduce evidence-based treatments for addressing PSD beyond the usual healthcare-channeled approaches (see Box 3).
To assess the implementation of the innovation and understand what worked, how and why, a mixed quantitative and qualitative methods approach for implementation science methodology would have to be used. 90, 91 iMOODS will require to define, a priori, some implementation outcomes: acceptability, adoption, appropriateness, feasibility, fidelity, and cost. 89 Different data collection methods could be considered. First, focus groups and short surveys with participants would elicit their preferences. Second, the iMOODS monitoring system will automatically collect and store data directly from the app that will describe in detail the participants' adherence and use of the tool. With regard to the intervention itself, assessment of depressive symptoms and other secondary outcomes will be measured and analyzed before and after the intervention. At the end of the intervention, a questionnaire and a semi-structured interview guide could collect
Box 1 iMOODS formative phase
Key informants Different people involved in the stroke care should be selected to take part in the first phase, for example, stroke survivors, caregivers, and healthcare providers with stroke working experience including professionals from psychology, psychiatry, neurology, and physiotherapy backgrounds. Engineers developing mHealth solutions for people with stroke and/or disabilities should be also considered.
Data collection methods
A semi-structured interview guide should be designed for each type of informant, and all interviewees should answer a brief questionnaire to collect demographic data and information about technology usage. Observations would need to be performed at stroke survivors' houses to assess Internet connectivity and use of technology devices in a real situation and to identify potential barriers for the following stages of the iMOODS Project.
information about participants' use of the application and their participation and interaction in the online support group, for example, frequency, favorite features, difficulties, etc. Also, participants should be invited to reflect on the perceived benefits on their mental and physical health; suggestions to improve them will be administered. All participants and caregivers, or a subsample, could be invited to a poststudy evaluation.
| CONCLUSIONS
The proposed iMOODS study concept cross-fertilizes the fields of mental health, stroke management, rehabilitation, information technology, and health systems, targeting a major problem such as PSD, affecting the most disenfranchised. It also applies synergistic constructs from behavioral and technology's uptake and usability theories Box 2 iMOODS production phase iMOODS core components PSD self-management application. The app would include a set of interactive sessions, delivered several times per week. The sessions will be a combination of text/audios, videos, quizzes, and interactive activities, aimed to increase patients' management of their condition and improve their mood. The app includes reminders to promote medication adherence, information of mental care services, etc.
Online support group platform. This platform would aim to take advantage of technology to offer the potential benefits of peer support, even when the stroke survivor has limited mobility or has a reduced social life because of depression. It should be available to all app users and including weekly group sessions, facilitated by a healthcare provider, but also forums and private chat rooms to be used on demand.
Monitoring system. This Web-based system should collect real-time information from all the app users. It should allow the project team to monitor participants' compliance with the intervention activities, to identify if somebody has no connectivity or needs help. It should also automatically store information to be used in the process evaluation of the intervention, that is, frequency of use of the app, favorite sessions, etc.
Data collection methods
Interviews and focus groups with both patients with PSD and their caregivers would capture user's acceptability and satisfaction data with the assembled package. Some usability evaluation techniques and tools, for example, http://www.usability.gov/, would explore the user experience from a different perspective, the commercial perspective, focused in what is needed to keep users engaged with and attached to the product.
Box 3 iMOODS testing phase
Participants
Patients with PSD would be eligible, including both prevalent and incident cases. Patients with a diagnosis of stroke within 6 months of onset, regardless of stroke subtype, and with clinically significant depressive symptoms (PHQ-9 score ≥10) would be considered eligible.
Patients with moderate or high suicide risk should be excluded and referred for adequate mental health care. Fieldworkers can assess eligibility and recruit patients with PSD at external consultations and rehabilitation services in both hospitals, using simple, validated, screening questionnaires that allow them to identify stroke to a somewhat reasonable degree as well as stroke neurologists. The Questionnaire for Verifying Stroke-Free Status (QVSFS) 92 and Del Brutto's Spanish version 93 are both effective at identifying stroke-free individuals with a high degree of accuracy and also have good accuracy as a screening tool for identifying subjects with stroke and/or transient ischemic attacks.
Training and technical support
Patients and caregivers-to provide support at home if necessary-would need to be trained in the use of iMOODS app and other components. Today, smartphones provide a suitable delivery channel to deploy training and intervention activities. Training videos, installed in the device, would be a necessary.
Outcomes and other measurements
Main outcome would be a reduction of at least 5 points in the PHQ-9 scale for the assessment of depressive symptoms. 94 PHQ-9 is a pragmatic and easy-to-use instrument that has been tested and recommended to measure depression in stroke patients. 95 Other variables that merit consideration for its collection, in addition to demographic and socioeconomic data, would include medication adherence (Morisky), activities of daily living and physical functioning (Barthel Index), dependency and disability (Modified Rankin Scale), quality of life (EQ-5D), and social support.
with direct user involvement. This combination is pragmatically translated into accruing values, opinion, and guidance from stroke pa- 
